Search results
Results from the WOW.Com Content Network
Hyperkalemia can occur following an overdose of spironolactone, and this is especially so in people with decreased kidney function. [8] Spironolactone has been studied at extremely high oral doses of up to 2,400 mg per day in clinical trials. [107] [168] Its oral median lethal dose (LD 50) is more than 1,000 mg/kg in mice, rats, and rabbits. [8]
However, spironolactone is metabolized to three active metabolites, which give it prolonged activity (13.8 – 16. 5 hours). Spironolactone has a long half-life and is excreted 47-51% through kidneys. Patients with chronic kidney disease therefore require close monitoring when taking the drug. Spironolactone is also eliminated through feces (35-41%
Spironolactone inhibits the effects of mineralocorticoids, namely, aldosterone, by displacing them from the mineralocorticoid receptor (MR) in the cortical collecting duct of kidney nephrons. This decreases the reabsorption of sodium and water while limiting the excretion of potassium.
Spironolactone is an acne treatment prescribed by dermatologists. Find out how spironolactone improves the appearance of hormonal acne, side effects, and more. Everything I Wish I Knew About ...
Increased risk of stomach problems, arthritis, kidney stones. On the reverse side, researchers found GLP-1 use was associated with an increased risk of gastrointestinal problems, including nausea ...
For premium support please call: 800-290-4726 more ways to reach us more ways to reach us
Kidney toxicity [5] associated with kidney failure; associated with development of cancer, particularly of the urinary tract, known carcinogen [8] [9] Atractylate Atractylis gummifera: Liver damage, [3] nausea, vomiting, epigastric and abdominal pain, diarrhoea, anxiety, headache and convulsions, often followed by coma [10]
Unlike spironolactone, bicalutamide has no antimineralocorticoid activity, [97] and for this reason, has no risk of hyperkalemia (which can, rarely/in severe cases, result in hospitalization or death) [112] or other antimineralocorticoid side effects such as urinary frequency, dehydration, hypotension, hyponatremia, metabolic acidosis, or ...